Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 7Nausea 7Lymphoma, Mantle-Cell 3Ovarian Neoplasms 2Lymphoma 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Papillomavirus Infections 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 13Doxorubicin 9Trastuzumab 8Taxes 7Paclitaxel 7Docetaxel 5Carboplatin 5Albumin-Bound Paclitaxel 5Radiotherapy 4Epirubicin 4pertuzumab 3pembrolizumab 3Melphalan 3130-nm albumin-bound paclitaxel 3eribulin 2Thiotepa 2Tamoxifen 2Peripheral Blood Stem Cell Transplantation 2Lapatinib 2Fluorouracil 2Filgrastim 2Bevacizumab 22C4 antibody 2trastuzumab biosimilar HLX02 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1romidepsin 1pegfilgrastim 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammatory Breast Neoplasms × Granisetron × Clear all
NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

University of Rochester

Phase 3 Completed
1,021 enrolled 10 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡